Delivery Order SPE2DB22D2214-SPE2DB24FS4MV
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Depo-Estradiol 5 mg/ml vials. The ceiling value of the contract is $3,502.70, with a performance period through May 6, 2024. This appears to be a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and supporting military healthcare programs globally. The...
- This federal contract award, valued at $1,808.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEPO-ESTRADIOL 5 MG/ML VIAL 5ML, a medical product. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
- The Defense Logistics Agency awarded a delivery order valued at $1,054.83 to AmerisourceBergen Drug Corp for Depo-Estradiol 5 mg/ml vials (5 ml) on September 17, 2025, with a completion date of September 18, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of DEPO-ESTRADIOL 5 MG/ML VIAL 5ML, a pharmaceutical product, with a ceiling value of $1,456.70 and an ultimate completion date of October 21, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,885.54 firm fixed-price delivery order is for the supply of 100 mg/5 ml vials of the prescription medication Delestrogen. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,176.60 delivery order to AmerisourceBergen Drug Corp for the supply of Estradiol Valerate 200 mg/5 ml in 5 ml vials, with a completion date of June 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under a larger vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,815.94 firm fixed-price delivery order is for the supply of "Estrogen-Methyltestos H.S. Tab 100s" and has an ultimate completion date of May 30, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,581.74 firm fixed-price delivery order is for the supply of ESTROGEN-METHYLTESTOS H.S. TAB 100S, a medical commodity. The contract has an ultimate completion date of March 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The award is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. Under this specific Delivery Order, Amerisourcebergen will provide the U.S. government with 4564933080 - ESTRADIOL 0.025 MG...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,569.22, is for the delivery of Estradiol 10 mcg vaginal inserts. The award does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB24FS4MVDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,251.69 Firm Fixed Price delivery order is for the supply of Depo-Estradiol 5 mg/ml vials. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for military treatment programs and facilities worldwide. This specific award does not have a set-aside designation. Amerisourcebergen has extensive experience fulfilling federal pharmaceutical and medical supply contracts, including for the Department of Justice Federal Bureau of Investigation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/22/24 |